Hirotoshi Sano1, Akira Satoh2, Yuichi Murayama2, Yoko Kato2, Hideki Origasa3, Joji Inamasu4, Mohsen Nouri5, Iype Cherian6, Nobuto Saito7. 1. WFNS Cerebrovascular Diseases and Therapy Committee. Electronic address: hsano@white-jack.jp. 2. WFNS Cerebrovascular Diseases and Therapy Committee. 3. Biostatistics and Clinical Epidemiology, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama-shi, Japan. 4. Department of Neurosurgery, Fujita Health University School of Medicine, Toyoake, Japan. 5. Department of Neurosurgery, Tehran University of Medical Sciences, Tehran, Iran. 6. Department of Neurosurgery, COMS Bharatpur, Bharatpur, Nepal. 7. Science Council, Japan Neurosurgical Society, Tokyo, Japan.
Abstract
OBJECT: A modified World Federation of Neurosurgical Societies scale (m-WFNS scale) for aneurysmal subarachnoid hemorrhage (SAH) recently has been proposed, in which patients with Glasgow Coma Scale (GCS) scores of 14 are assigned to grade II and those with GCS scores of 13 are assigned to grade III regardless of the presence of neurologic deficits. The study objective was to evaluate outcome predictability of the m-WFNS scale in a large cohort. METHODS: This was a multicenter prospective observational study conducted in Japan. A total of 1656 patients with SAH were registered during the 2.5-year study period, and the outcome predictability, using the Glasgow Outcome Scale (GOS) and modified Rankin Scale (mRS) scores at discharge and at 90 days after onset, was evaluated by comparing the m-WFNS with the original WFNS scale. We focused on whether significant differences in these scores were present between the neighboring grades. RESULTS: In the m-WFNS scale, significant difference between any neighboring grades was observed both in the mean GOS and mRS scores at 90 days except between grades III/IV. However, differences were not significant between grades II/III and between grades III/IV in the original WFNS scale. CONCLUSIONS: SAH-induced brain injury may be substantially severer in patients with GCS 13 than those with GCS 14, which may explain why grade III patients faired significantly worse than grade II patients by the modified WFNS scale. Although further validation is necessary, the m-WFNS scale has a potential of providing neurosurgeons with simpler and more reliable prognostication of patients with SAH.
OBJECT: A modified World Federation of Neurosurgical Societies scale (m-WFNS scale) for aneurysmal subarachnoid hemorrhage (SAH) recently has been proposed, in which patients with Glasgow Coma Scale (GCS) scores of 14 are assigned to grade II and those with GCS scores of 13 are assigned to grade III regardless of the presence of neurologic deficits. The study objective was to evaluate outcome predictability of the m-WFNS scale in a large cohort. METHODS: This was a multicenter prospective observational study conducted in Japan. A total of 1656 patients with SAH were registered during the 2.5-year study period, and the outcome predictability, using the Glasgow Outcome Scale (GOS) and modified Rankin Scale (mRS) scores at discharge and at 90 days after onset, was evaluated by comparing the m-WFNS with the original WFNS scale. We focused on whether significant differences in these scores were present between the neighboring grades. RESULTS: In the m-WFNS scale, significant difference between any neighboring grades was observed both in the mean GOS and mRS scores at 90 days except between grades III/IV. However, differences were not significant between grades II/III and between grades III/IV in the original WFNS scale. CONCLUSIONS:SAH-induced brain injury may be substantially severer in patients with GCS 13 than those with GCS 14, which may explain why grade III patients faired significantly worse than grade II patients by the modified WFNS scale. Although further validation is necessary, the m-WFNS scale has a potential of providing neurosurgeons with simpler and more reliable prognostication of patients with SAH.
Authors: W E van der Steen; H A Marquering; L A Ramos; R van den Berg; B A Coert; A M M Boers; M D I Vergouwen; G J E Rinkel; B K Velthuis; Y B W E M Roos; C B L M Majoie; W P Vandertop; D Verbaan Journal: AJNR Am J Neuroradiol Date: 2020-05-14 Impact factor: 3.825
Authors: Hernán Bayona; Brenda Ropero; Antonio José Salazar; Juan Camilo Pérez; Manuel Felipe Granja; Carlos Fernando Martínez; Juan Nicolás Useche Journal: J Med Internet Res Date: 2020-07-27 Impact factor: 5.428
Authors: Ju Young Hong; Je Sung You; Min Joung Kim; Hye Sun Lee; Yoo Seok Park; Sung Phil Chung; Incheol Park Journal: BMJ Open Date: 2019-02-20 Impact factor: 2.692
Authors: Xian Wei Su; Anna Ho Yin Chan; Gang Lu; Marie Lin; Johnny Sze; Jing Ye Zhou; Wai Sang Poon; Qiang Liu; Vera Zhi Yuan Zheng; George Kwok Chu Wong Journal: PLoS One Date: 2015-12-16 Impact factor: 3.240
Authors: Megan A Hird; Kristin A Vesely; Tahira Tasneem; Gustavo Saposnik; R Loch Macdonald; Tom A Schweizer Journal: Front Neurol Date: 2018-02-13 Impact factor: 4.003